Related Experiment Video
Updated: Jul 29, 2026

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
Bickerstaff's brainstem encephalitis in childhood: a literature overview
1Pediatric and Pediatric Emergency Department, University Hospital "Policlinico-San Marco, Catania, Italy. ppavone@unict.it.
Insights
Bickerstaff brainstem encephalitis in children is uncommon. Immunotherapy speeds symptom recovery, but neuroimaging changes may prolong healing time, impacting prognosis.
Area of Science:
- Neurology
- Pediatric Neurology
- Infectious Diseases
Background:
- Bickerstaff brainstem encephalitis (BBE) is a rare neurological disorder.
- Understanding pediatric BBE is crucial for timely diagnosis and management.
Purpose of the Study:
- To review the clinical presentation, diagnosis, and treatment of pediatric Bickerstaff brainstem encephalitis.
- To identify factors influencing recovery and prognosis in children with BBE.
Main Methods:
- Systematic review of pediatric BBE cases (age ≤ 18) from major databases (PubMed, Cochrane, Scopus).
- Inclusion based on age and clinical characteristics of BBE.
- Analysis of 236 pediatric cases from 27 articles (1990-2020).
Main Results:
- Pediatric BBE phenotype aligns with existing literature.
- Anti-GQ1b antibody positivity was observed in nearly half of cases but did not correlate with healing time.
- Neuroimaging abnormalities were associated with longer recovery periods.
- Immunotherapy (IVIg, steroids, plasmapheresis) led to faster symptom resolution compared to supportive care.
Conclusions:
- Bickerstaff brainstem encephalitis is rare, with prognosis influenced by clinical presentation, comorbidities, investigations, and treatment timing.
- Early immunotherapy appears beneficial for symptom resolution in pediatric BBE.
- Neuroimaging findings are important prognostic indicators for recovery duration.
Objective:
This is a review on clinical presentation, diagnosis, and treatment of reported cases of Bickerstaff brain encephalitis.
Materials And Methods:
Cases of pediatric Bickerstaff's brainstem encephalitis collected from PubMed, Cochrane Library and Scopus Web of Science databases were reviewed. The inclusion criteria of the cases were based on age ≤ 18 years and the clinical characteristics of the disorder.
Results:
Twenty-seven articles on Bickerstaff's brainstem encephalitis, including 236 children from a total of 42 from January 1990 to January 2020, were selected. The phenotype of the pediatric cases confirmed those described in the previously published articles. Almost half of the cases demonstrated the positivity of anti-GQ1b antibody titers, but the antibodies' presence was not linked to longer healing time. However, it was found that individuals with neuroimaging changes needed a longer time to recovery. Overall, patients treated with any type of immunotherapy (intravenous immunoglobulins, steroid or plasmapheresis) demonstrated faster resolution of symptoms than supportive care.
Conclusions:
Bickerstaff's brainstem encephalitis is an uncommon disorder, the short-term and long-term prognoses depend on the clinical presentation of the disorder, co-morbidity, instrumental investigations, and precocity of treatment.
More Related Videos
Related Concept Videos
Bacterial Meningitis
Arboviral Encephalitis
Bacterial Meningitis I: Introduction
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Brain Abscess l: Introduction

